121 related articles for article (PubMed ID: 7970120)
1. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.
Jörres A; Gahl GM; Topley N; Neubauer A; Ludat K; Müller C; Passlick-Deetjen J
Nephrol Dial Transplant; 1994; 9(7):785-90. PubMed ID: 7970120
[TBL] [Abstract][Full Text] [Related]
2. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
3. Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes.
Plum J; Lordnejad MR; Grabensee B
Kidney Int; 1998 Jul; 54(1):224-35. PubMed ID: 9648083
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
5. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
6. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
[TBL] [Abstract][Full Text] [Related]
7. In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis.
Jörres A; Gahl GM; Ludat K; Frei U; Passlick-Deetjen J
Nephrol Dial Transplant; 1997 Mar; 12(3):543-9. PubMed ID: 9075138
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD
Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.
Jörres A; Topley N; Steenweg L; Müller C; Köttgen E; Gahl GM
Am J Nephrol; 1992; 12(1-2):80-5. PubMed ID: 1415370
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
[TBL] [Abstract][Full Text] [Related]
11. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
12. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis solution pH and Ca2+ concentration regulate peritoneal macrophage and mesothelial cell activation.
Carozzi S; Caviglia PM; Nasini MG; Schelotto C; Santoni O; Pietrucci A
ASAIO J; 1994; 40(1):20-3. PubMed ID: 8186487
[TBL] [Abstract][Full Text] [Related]
14. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility studies with bicarbonate-based solutions.
Pedersen FB
Adv Perit Dial; 1994; 10():245-50. PubMed ID: 7999838
[TBL] [Abstract][Full Text] [Related]
16. Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
Sayarlioglu H; Topal C; Sayarlioglu M; Dulger H; Dogan E; Erkoc R
Mediators Inflamm; 2004 Apr; 13(2):119-21. PubMed ID: 15203553
[TBL] [Abstract][Full Text] [Related]
17. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.
Tsuboi I; Tanaka H; Nakao M; Shichijo S; Itoh K
Cytokine; 1995 May; 7(4):372-9. PubMed ID: 8589268
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
Jang CH; Choi JH; Byun MS; Jue DM
Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
